Gerald W. Verhaegh

7.0k total citations · 1 hit paper
97 papers, 4.6k citations indexed

About

Gerald W. Verhaegh is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gerald W. Verhaegh has authored 97 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 35 papers in Pulmonary and Respiratory Medicine and 33 papers in Cancer Research. Recurrent topics in Gerald W. Verhaegh's work include Prostate Cancer Treatment and Research (32 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Cancer-related molecular mechanisms research (12 papers). Gerald W. Verhaegh is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Cancer-related molecular mechanisms research (12 papers). Gerald W. Verhaegh collaborates with scholars based in Netherlands, United States and Japan. Gerald W. Verhaegh's co-authors include Jack A. Schalken, Frank Smit, Daphne Hessels, Pierre Hainaut, Lambertus A. Kiemeney, Marion J.G. Bussemakers, Adrie van Bokhoven, F.M.J. Debruyne, Herbert F.M. Karthaus and Ning Ru and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gerald W. Verhaegh

94 papers receiving 4.5k citations

Hit Papers

DD3: a new prostate-speci... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
    1999 809 citations Marion J.G. Bussemakers, Adrie van Bokhoven et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald W. Verhaegh Netherlands 31 2.7k 1.9k 1.8k 822 552 97 4.6k
Adrie van Bokhoven United States 35 2.5k 0.9× 1.1k 0.5× 1.6k 0.9× 992 1.2× 379 0.7× 74 4.6k
Michael C. Haffner United States 34 2.8k 1.1× 1.5k 0.8× 2.5k 1.4× 1.2k 1.4× 314 0.6× 120 5.3k
Richard Flavin Ireland 31 2.0k 0.8× 1.6k 0.8× 822 0.5× 763 0.9× 293 0.5× 90 3.6k
Guro E. Lind Norway 39 3.0k 1.1× 1.5k 0.8× 764 0.4× 1.3k 1.6× 788 1.4× 89 4.8k
Masaki Shiota Japan 39 2.3k 0.8× 1.1k 0.5× 2.0k 1.1× 945 1.1× 444 0.8× 253 4.3k
Bharathi Laxman United States 28 4.5k 1.7× 2.6k 1.4× 2.4k 1.3× 769 0.9× 256 0.5× 38 6.4k
Kazuya Shinmura Japan 37 3.1k 1.2× 1.1k 0.6× 691 0.4× 1.2k 1.4× 477 0.9× 142 4.6k
Shancheng Ren China 30 2.1k 0.8× 1.4k 0.7× 992 0.6× 895 1.1× 236 0.4× 78 3.5k
Sarki A. Abdulkadir United States 38 2.6k 1.0× 881 0.5× 998 0.6× 1.2k 1.5× 295 0.5× 93 4.4k
Tarek A. Bismar Canada 37 2.4k 0.9× 1.3k 0.7× 2.6k 1.5× 1.1k 1.3× 302 0.5× 129 4.8k

Countries citing papers authored by Gerald W. Verhaegh

Since Specialization
Citations

This map shows the geographic impact of Gerald W. Verhaegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald W. Verhaegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald W. Verhaegh more than expected).

Fields of papers citing papers by Gerald W. Verhaegh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald W. Verhaegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald W. Verhaegh. The network helps show where Gerald W. Verhaegh may publish in the future.

Co-authorship network of co-authors of Gerald W. Verhaegh

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald W. Verhaegh. A scholar is included among the top collaborators of Gerald W. Verhaegh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald W. Verhaegh. Gerald W. Verhaegh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wen, et al.. (2024). TempEasy 3D Hydrogel Coculture System Provides Mechanistic Insights into Prostate Cancer Bone Metastasis. ACS Applied Materials & Interfaces. 16(20). 25773–25787. 2 indexed citations
2.
3.
4.
Hooij, Onno van, Tilly Aalders, Emiliano Cocco, et al.. (2023). Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors. Oral Oncology. 137. 106297–106297. 3 indexed citations
5.
6.
Uijen, Maike J.M., Adriana C. H. van Engen–van Grunsven, Yuichiro Tada, et al.. (2020). Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. Cancer Treatment Reviews. 89. 102069–102069. 35 indexed citations
7.
Bijnsdorp, Irene V., et al.. (2020). The prostate cancer urinary exosome protein biomarker landscape. European Urology Open Science. 19. e517–e518. 1 indexed citations
8.
9.
Boxtel, Wim van, Gerald W. Verhaegh, Dianne van Strijp, et al.. (2019). Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients. International Journal of Cancer. 146(11). 3196–3206. 24 indexed citations
10.
Boxtel, Wim van, Laura D. Locati, Adriana C. H. van Engen–van Grunsven, et al.. (2019). Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma. European Journal of Cancer. 110. 62–70. 48 indexed citations
11.
Hooij, Onno van, Frank Smit, Paula I. van Noort, et al.. (2017). miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2. Cancer Research. 77(8). 2008–2017. 48 indexed citations
12.
Herpen, Carla M.L. van, Wim van Boxtel, Uta Flucke, et al.. (2017). Overexpression of the c-MET proto-oncogene in salivary duct carcinoma patients. Annals of Oncology. 28. v374–v374. 2 indexed citations
13.
Bijnsdorp, Irene V., Martin E. van Royen, Gerald W. Verhaegh, & Elena S. Martens‐Uzunova. (2017). The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice. Molecular Diagnosis & Therapy. 21(4). 385–400. 18 indexed citations
14.
Janssen, Dick, Theo Hafmans, Gerald W. Verhaegh, et al.. (2016). TRPV4 channels in the human urogenital tract play a role in cell junction formation and epithelial barrier. Acta Physiologica. 218(1). 38–48. 20 indexed citations
15.
Hamid, Agus Rizal Ardy Hariandy, et al.. (2014). Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy. Prostate International. 2(3). 105–113. 28 indexed citations
16.
Verhaegh, Gerald W., et al.. (2014). Noncoding RNAs as Novel Biomarkers in Prostate Cancer. BioMed Research International. 2014. 1–17. 73 indexed citations
17.
Iljin, Kristiina, Maija Wolf, Henrik Edgren, et al.. (2006). TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming. Cancer Research. 66(21). 10242–10246. 180 indexed citations
18.
Verhaegh, Gerald W., Jacques B de Kok, Daphne Hessels, Frank Smit, & Jack A. Schalken. (2003). DD3, a very sensitive and specific merker to detect prostate tumors. Reply to: Gandino O, Santulli M, Cardillo MR, Stigliano A, Toscano V. Correspondence re: J.B. de Kok et al.. Cancer Research. 63. 4748–4749. 2 indexed citations
19.
Verhaegh, Gerald W., Rian Roelofs, Daphne Hessels, et al.. (2002). hTERT and DD3/PCA3 gene expression in prostatic tissues: differentiation between normal prostate, benign prostate hyperplasia and prostate tumours. European Urology Supplements. 1(1). 7–7. 1 indexed citations
20.
Verhaegh, Gerald W., Adrie van Bokhoven, Frank Smit, Jack A. Schalken, & Marion J.G. Bussemakers. (2000). Isolation and Characterization of the Promoter of the Human Prostate Cancer-specific DD3 Gene. Journal of Biological Chemistry. 275(48). 37496–37503. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrie van Bokhoven Breakdown of academic impact, for papers by Michael C. Haffner Breakdown of academic impact, for papers by Richard Flavin Breakdown of academic impact, for papers by Guro E. Lind Breakdown of academic impact, for papers by Masaki Shiota Breakdown of academic impact, for papers by Bharathi Laxman Breakdown of academic impact, for papers by Kazuya Shinmura Breakdown of academic impact, for papers by Shancheng Ren Breakdown of academic impact, for papers by Sarki A. Abdulkadir Breakdown of academic impact, for papers by Tarek A. Bismar
Rankless by CCL
2026